| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |